The tariff classification of Maraviroc Tablets in dosage form, from India
Issued June 9, 2023 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9207
Headings: 3004
Product description
Maraviroc, imported in 150 mg and 300 mg tablets, is an antiretroviral medication. It is indicated for use in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients 2 years of age and older weighing at least 10 kg.
CBP rationale
The applicable subheading for the Maraviroc Tablets in dosage form will be 3004.90.9207, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Anti-infective medicaments: Antivirals.
Full text
N332860 June 9, 2023 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3004.90.9207 Pradeep Shah Zydus Pharmaceuticals USA Inc. 73 Route 31 NPennington, NJ 08534 RE: The tariff classification of Maraviroc Tablets in dosage form, from India Dear Mr. Shah: In your letter dated May 11, 2023, you requested a tariff classification ruling. Maraviroc, imported in 150 mg and 300 mg tablets, is an antiretroviral medication. It is indicated for use in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients 2 years of age and older weighing at least 10 kg. The applicable subheading for the Maraviroc Tablets in dosage form will be 3004.90.9207, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Anti-infective medicaments: Antivirals.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs and Border Protection Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, please contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in dosage form, from India
The tariff classification of VEMLIDY® Tablets (Tenofovir Alafenamide) in dosage form, from Canada
The tariff classification of Valganciclovir Tablets in dosage form, from Italy
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →